Literature DB >> 31289477

STAT6 phosphorylation upregulates microRNA-155 expression and subsequently enhances the pathogenesis of chronic lymphocytic leukemia.

Na Chen1, Lili Feng1, Kang Lu1, Peipei Li1, Xiao Lv1, Xin Wang1,2.   

Abstract

Chronic lymphocytic leukemia (CLL), a clonal expansion of CD5+ B cells, is the most common form of adult leukemia; however, the molecular mechanisms underlying its pathogenesis remain undetermined. It has been previously suggested that numerous biological factors, including cytokines, may be involved in the proliferation of malignant cells. For example, interleukin (IL)-4, IL-2, interferon-γ and tumor necrosis factor serve roles as inhibitors of cellular apoptosis; whereas IL-5 and IL-10 are inducers of cellular apoptosis. In the present study, the results demonstrated that the phosphorylation and activation of signal transducer and activator of transcription 6 (STAT6) was induced by IL-4 in a time-dependent manner. Notably, the expression level of microRNA (miR)-155 was increased in MEC-1 cells following treatment with IL-4; however, this effect was attenuated following STAT6 knockdown via RNA interference. In addition, STAT6 knockdown promoted cell apoptosis, which was partly attenuated by treatment with IL-4. Inhibition of miR-155 expression significantly increased cell apoptosis despite the presence of IL-4. The results of the present study suggested that treatment with IL-4 enhanced the expression of miR-155, which regulated CLL cell survival via the enhanced phosphorylation of STAT6.

Entities:  

Keywords:  chronic lymphocytic leukemia; interleukin-4; microRNA-155; signal transducer and activator of transcription 6

Year:  2019        PMID: 31289477      PMCID: PMC6540395          DOI: 10.3892/ol.2019.10294

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  5 in total

1.  GATA3 Inhibits Viral Infection by Promoting MicroRNA-155 Expression.

Authors:  Jiaxin Li; Areayi Haiyilati; Linyi Zhou; Juncheng Chen; Yongqiang Wang; Li Gao; Hong Cao; Xiaoqi Li; Shijun J Zheng
Journal:  J Virol       Date:  2022-03-23       Impact factor: 6.549

2.  miR‑144‑3p inhibits tumor cell growth and invasion in oral squamous cell carcinoma through the downregulation of the oncogenic gene, EZH2.

Authors:  Longlong He; Lifan Liao; Liangzhi Du
Journal:  Int J Mol Med       Date:  2020-06-11       Impact factor: 4.101

Review 3.  MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia.

Authors:  Katerina Katsaraki; Paraskevi Karousi; Pinelopi I Artemaki; Andreas Scorilas; Vasiliki Pappa; Christos K Kontos; Sotirios G Papageorgiou
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639

4.  Up-regulation of miR-155 potentiates CD34+ CML stem/progenitor cells to escape from the growth-inhibitory effects of TGF-ß1 and BMP signaling.

Authors:  Touba Mahdloo; Pantea Sahami; Reihaneh Ramezani; Mojtaba Jafarinia; Hamedreza Goudarzi; Sadegh Babashah
Journal:  EXCLI J       Date:  2021-04-15       Impact factor: 4.068

5.  Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients.

Authors:  L Karabon; A Partyka; L Ciszak; E Pawlak-Adamska; A Tomkiewicz; A Bojarska-Junak; J Roliński; D Wołowiec; T Wrobel; I Frydecka; A Kosmaczewska
Journal:  J Immunol Res       Date:  2020-07-28       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.